Patents by Inventor Johan Lindh

Johan Lindh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AN ALPHA TYPE STIRLING ENGINE
    Publication number: 20250043746
    Abstract: An alpha type Stirling engine, comprising four pistons housed in respective chambers for reciprocating movement, at least two linear motors/generators configured to cause said pistons to move in the respective chambers, each one of said pistons defining in its respective chamber a primary chamber side located on one side of the piston and a secondary chamber side located on the other side of the piston. The Stirling engine comprises two primary gas channels, each one fluidly interconnecting two primary chamber sides. The Stirling engine also comprises two secondary gas channels, each one fluidly interconnecting two secondary chamber sides in different chamber combinations than the interconnections achieved by the primary gas channels.
    Type: Application
    Filed: December 1, 2022
    Publication date: February 6, 2025
    Applicant: EnergyIntel Services Ltd.
    Inventors: Martin Nilsson, Fredrik Slätte, Johan Lindh, Peter Weber
  • Selection of RNA-aptamers as anti-malaria agents
    Patent number: 9309517
    Abstract: The present invention relates to an aptamer or an active fragment thereof raised against the semi-conserved duffy binding ligand domain 1?, DBL1?, region of the Plasmodium falciparum erythrocyte membrane protein 1, PfEMPI, which aptamer has an effect against malaria, in particular severe cerebral malaria.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: April 12, 2016
    Assignee: APTAHEM AB
    Inventors: Johan Lindh, Tina Persson
  • Selection of RNA-aptamers as anti-malaria agents
    Patent number: 9309516
    Abstract: The present invention relates to an aptamer or an active fragment thereof raised against the semi-conserved duffy binding ligand domain 1?, DBL1?, region of the Plasmodium falciparum erythrocyte membrane protein 1, PfEMPI, which aptamer has an effect against malaria, in particular severe cerebral malaria.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: April 12, 2016
    Assignee: APTAHEM AB
    Inventors: Johan Lindh, Tina Persson
  • SELECTION OF RNA-APTAMERS AS ANTI-MALARIA AGENTS
    Publication number: 20160040164
    Abstract: The present invention relates to an aptamer or an active fragment thereof raised against the semi-conserved duffy binding ligand domain 1?, DBL1?, region of the Plasmodium falciparum erythrocyte membrane protein 1, PfEMPI, which aptamer has an effect against malaria, in particular severe cerebral malaria.
    Type: Application
    Filed: July 31, 2015
    Publication date: February 11, 2016
    Inventors: Johan LINDH, Tina PERSSON
  • SELECTION OF RNA-APTAMERS AS ANTI-MALARIA AGENTS
    Publication number: 20160032293
    Abstract: The present invention relates to an aptamer or an active fragment thereof raised against the semi-conserved duffy binding ligand domain 1?, DBL1?, region of the Plasmodium falciparum erythrocyte membrane protein 1, PfEMPI, which aptamer has an effect against malaria, in particular severe cerebral malaria.
    Type: Application
    Filed: July 31, 2015
    Publication date: February 4, 2016
    Inventors: Johan LINDH, Tina PERSSON
  • Selection of RNA-aptamers as anti-malaria agents
    Patent number: 9096857
    Abstract: The present invention relates to an aptamer or an active fragment thereof raised against the semi-conserved duffy binding ligand domain 1?, DBL1?, region of the Plasmodium falciparum erythrocyte membrane protein 1, PfEMPI, which aptamer has an effect against malaria, in particular severe cerebral malaria.
    Type: Grant
    Filed: February 5, 2009
    Date of Patent: August 4, 2015
    Assignee: APTAHEM AB
    Inventors: Johan Lindh, Tina Persson
  • SELECTION OF RNA APTAMERS AS ANTI-MALARIA AGENTS
    Publication number: 20110003886
    Abstract: The present invention relates to an aptamer or an active fragment thereof raised against the semi-conserved duffy binding ligand domain 1?, DBL1?, region of the Plasmodium falciparum erythrocyte membrane protein 1, PfEMPI, which aptamer has an effect against malaria, in particular severe cerebral malaria.
    Type: Application
    Filed: February 5, 2009
    Publication date: January 6, 2011
    Applicant: FORSKARPATENT I SYD AB
    Inventors: Johan Lindh, Tina Persson